The completion of Pfizer’s deal to acquire Wyeth has been followed swiftly by news that a number of manufacturing and …
Pfizer expects to complete its $68 billion acquisition of Wyeth today after receiving sign-off on the deal from regulators in …
The make-up of Merck and Schering-Plough's new corporate entity became clearer this week. Referred to as the 'new Merck' and …
Specialist pharma company Warner Chilcott is to buy Procter & Gamble's pharmaceutical division for $3.1 billion, turning it into a …
Australian company Amcor looks set to join the healthcare packaging giants via a $2 billion deal to purchase the pharmaceutical, …
Merck and Schering-Plough's legal battles with their shareholders may be approaching a truce. Two class action lawsuits earlier this year …
Bristol-Myers Squibb is to spend $2.1 billion in buying Medarex, the human antibody drug discovery specialists. Princeton-based Medarex is best …
Takeda has gained the rights to the first treatment for a new malignant bone cancer affecting children and young adults. …
GSK has acquired Stiefel, the world's largest independent dermatology company, in a deal valued up to $3.6 billion. The move …
Pfizer has unveiled the new structure of the merged company created by its proposed acquisition of Wyeth. It plans to …
As a standalone company, Merck & Co. faces a tough future of declining sales. Analysts Datamonitor forecast that the merger …
Roche has finally struck a deal to acquire Genentech after raising its cash offer, putting an end to a prolonged …
Merck is to acquire Schering-Plough for $41.1 billion, creating a new industry giant to challenge Pfizer in terms of its …
In retrospect, Pfizer's move to buy another major pharmaceutical company was inevitable. Like its peers, Pfizer has been energetically restructuring …
Roche has launched a renewed bid to buy out Genentech, making a 'hostile' bid for the company by appealing directly …